Hello, everyone, and how are you this morning? We hope the weekend was refreshing and invigorating, because now the time has come to resume that challenging routine of meetings, deadlines and other mountains to climb. So please join us for that mandatory cup or three of stimulation, which we confess is desperately needed. There is so much to do that our venerable to-do list requires separate sections. Oh boy. Meanwhile, here are some fresh tidbits for your edification. Have a great day, or at least survive, and stay in touch if you hear something interesting...
Glaxo Hopes For Key Trial Results On 14 Drugs (Reuters)
Supreme Court Rejects Appeal By Fen-Phen Lawyer (Reuters)
Sandoz Closes Finished Med Plant In Mumbai; Cuts 150 Jobs (Hindu Business Line)
Drugmakers Increase Search For Hearing Loss Medicines (Reuters)
J&J Wins Reversal Of $1.1M Levaquin Lawsuit (Bloomberg News)
Neglected Disease R&D Spending Is Up, But Few New Meds (Pharma Times)
AMRI To Close US Site & Shift Work To Singapore (Outsourcing Pharma)
Merck Serono And NeoPharma Ink Mideast Production Pact (Khaleej Times)
Merck KGgA Eyes Expansion In Indonesia (Jakarta Globe)
EDITOR'S NOTE: Please check this post for updates
sunrise pic thx to benimoto on flickr